Revenue Approved EIIS Investment Opportunity 2022
in 2023 for qualifying Irish taxpayers
per annum (including tax relief at the marginal rate)
Amount: Minimum €5,000 | Maximum €250,000 each per individual in a marriage or civil partnership.
Type: Cumulative Redeemable Preference Shares
Closing: Thursday 22nd December 2022
Company: Wild Atlantic Health Ltd
Location: Cork, Ireland
Sector: Preventative Health Tech
Stage: Revenue generating
Company Reg No: 627 336
EIIS: Revenue Approved Scheme
Post-Covid, we are seeing a convergence of trends encompassing Digital Health, Sustainability and Personalisation.
Wild Atlantic is the first company in Ireland to offer a painless home test to measure deficiencies and then back this up with lifestyle recommendations and supplements that really work.
We are seeking to raise investment to rapidly grow the business in the Irish market to replicate the model in international markets. So if you’re an investor interested in health, sustainability and backing the business – we’d love to tell you about our EIIS Investment Opportunity 2022.
In a market where people don’t know which supplements to take or what’s really working, Wild Atlantic eliminates the guesswork by bringing a fresh new evidence-based perspective to preventative health.
Our mission is to bring more wellbeing into the world, empowering people to live longer, healthier and happier lives.
Our Home Tests provide a baseline for better health by identifying nutrient gaps in advance while offering lifestyle recommendations and supplement solutions.
As a D2C challenger brand, we are taking on the outdated supplement industry valued globally at $151.9 billion (2021) and forecast to grow at an 8.9% CAGR from 2022 to 2030.
Revenue-approved EIIS investment opportunity 2022
Save up to 40% on your Income Tax!
Get on board.
Avoid negative bank interest rates with our inflation busting investment opportunity.
The staggering growth in Digital Health investment has increased from $1.2 Billion in 2010 to $44 Billion in 2022
Call Jonathan: 085 777 8262 or Tanja on 083 025 3484 today.
To receive a Summary of the EIIS Investment Opportunity 2022, please complete your details.
RISK WARNING – Investing in start-ups involves risks, including illiquidity, lack of dividends, loss of investment and dilution, and it should be done only as part of a diversified portfolio. Before investing, please seek professional finance & tax advice.